Literature DB >> 27791227

Sarcopenic Obesity and Metabolic Syndrome in Adult Caucasian Subjects.

E Poggiogalle1, C Lubrano, G Sergi, A Coin, L Gnessi, S Mariani, A Lenzi, L M Donini.   

Abstract

OBJECTIVES: Recently metabolic aspects linked to sarcopenic obesity (SO) were investigated. Extant studies involved especially older people from Asian or White-mixed American cohorts. THE AIMS OF OUR STUDY WERE: to explore the prevalence of sarcopenia in Caucasian adult obese subjects using two different indices of sarcopenia, and to investigate the relationship among SO, metabolic syndrome (MS), inflammation, and serum albumin concentrations.
DESIGN: Cross- sectional study. SUBJECTS/
METHODS: The study was performed from 2011 to 2014 in a hospitalized care setting. Inclusion criteria were: age>18 and <65 years, BMI≥30 Kg/m2. Fat mass (FM) and fat-free mass (FFM) were assessed by DXA. Appendicular skeletal muscle mass (ASMM) was calculated. Sarcopenia was defined as ASMM/height2 or ASMM/weight <2SD than the sex-specific mean of a young population. The cutoffs were ASMM/h2<6.54 Kg/m2 for men and 4.82 Kg/m2 for women, and ASMM/weight<0.2827 for men and 0.2347 for women. ISI-Matsuda was calculated. MS was diagnosed (NCEP-ATPIII).
RESULTS: 727 subjects (age: 45.72±13.56 years, BMI: 37.74±5.82 kg/m2) were enrolled. The prevalence of SO was 1.0% or 34.8% in men and 0.6% or 50.1% in women, using ASMM/height2 ratio or ASMM/weight. Subjects with SO based on ASMM/height2 were scarce, only data relying on ASMM/weight were considered. Subjects with SO had higher BMI, waist circumference, FM, and lower FFM and ASMM than nonsarcopenic obese individuals (all p<0.05). ISI-Matsuda was lower and hs-CRP levels were higher in subjects with SO (all p<0.05). MS was more prevalent in subjects with SO than nonsarcopenic obese subjects (47.6% vs 34.3%, p<0.001). ASMM/weight was decreased in subjects with MS (0.2522±0.0410 vs 0.2423±0.0352, p=0.001).
CONCLUSION: SO is associated with MS and low- grade inflammation in adult Caucasian subjects. Metabolic profile evaluation should be recommended in subjects with SO.

Entities:  

Mesh:

Year:  2016        PMID: 27791227     DOI: 10.1007/s12603-015-0638-1

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  42 in total

1.  Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study.

Authors:  T N Kim; S J Yang; H J Yoo; K I Lim; H J Kang; W Song; J A Seo; S G Kim; N H Kim; S H Baik; D S Choi; K M Choi
Journal:  Int J Obes (Lond)       Date:  2009-06-30       Impact factor: 5.095

Review 2.  Sarcopenic obesity: A Critical appraisal of the current evidence.

Authors:  C M M Prado; J C K Wells; S R Smith; B C M Stephan; M Siervo
Journal:  Clin Nutr       Date:  2012-07-17       Impact factor: 7.324

3.  Additional role of sarcopenia to waist circumference in predicting the odds of metabolic syndrome.

Authors:  Seung Ha Park; Jae Hee Park; Ha Young Park; Hang Jea Jang; Hyun Kuk Kim; Jinse Park; Kyong Jin Shin; Jung Goo Lee; Young Soo Moon
Journal:  Clin Nutr       Date:  2013-08-31       Impact factor: 7.324

4.  Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly.

Authors:  Richard N Baumgartner; Sharon J Wayne; Debra L Waters; Ian Janssen; Dympna Gallagher; John E Morley
Journal:  Obes Res       Date:  2004-12

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Analytes and Metabolites Associated with Muscle Quality in Young, Healthy Adults.

Authors:  Michael S Lustgarten; Lori Lyn Price; Roger A Fielding
Journal:  Med Sci Sports Exerc       Date:  2015-08       Impact factor: 5.411

7.  Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

Authors:  Ian Janssen; Steven B Heymsfield; Robert Ross
Journal:  J Am Geriatr Soc       Date:  2002-05       Impact factor: 5.562

Review 8.  Sarcopenic obesity: definition, cause and consequences.

Authors:  Sari Stenholm; Tamara B Harris; Taina Rantanen; Marjolein Visser; Stephen B Kritchevsky; Luigi Ferrucci
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-11       Impact factor: 4.294

9.  Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study.

Authors:  Tae Nyun Kim; Man Sik Park; Kang Il Lim; Hae Yoon Choi; Sae Jeong Yang; Hye Jin Yoo; Hyun Joo Kang; Wook Song; Hyuk Choi; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

10.  Sarcopenic obesity is closely associated with metabolic syndrome.

Authors:  Chia-Wen Lu; Kuen-Cheh Yang; Hao-Hsiang Chang; Long-Teng Lee; Ching-Yu Chen; Kuo-Chin Huang
Journal:  Obes Res Clin Pract       Date:  2013 Jul-Aug       Impact factor: 2.288

View more
  15 in total

1.  Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.

Authors:  Lorenzo M Donini; Luca Busetto; Stephan C Bischoff; Tommy Cederholm; Maria D Ballesteros-Pomar; John A Batsis; Juergen M Bauer; Yves Boirie; Alfonso J Cruz-Jentoft; Dror Dicker; Stefano Frara; Gema Frühbeck; Laurence Genton; Yftach Gepner; Andrea Giustina; Maria Cristina Gonzalez; Ho-Seong Han; Steven B Heymsfield; Takashi Higashiguchi; Alessandro Laviano; Andrea Lenzi; Ibolya Nyulasi; Edda Parrinello; Eleonora Poggiogalle; Carla M Prado; Javier Salvador; Yves Rolland; Ferruccio Santini; Mireille J Serlie; Hanping Shi; Cornel C Sieber; Mario Siervo; Roberto Vettor; Dennis T Villareal; Dorothee Volkert; Jianchun Yu; Mauro Zamboni; Rocco Barazzoni
Journal:  Obes Facts       Date:  2022-02-23       Impact factor: 4.807

2.  Association of muscle mass and fat mass with insulin resistance and the prevalence of metabolic syndrome in Korean adults: a cross-sectional study.

Authors:  Kyuwoong Kim; Sang Min Park
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

3.  Total energy intake according to the level of skeletal muscle mass in Korean adults aged 30 years and older: an analysis of the Korean National Health and Nutrition Examination Surveys (KNHANES) 2008-2011.

Authors:  Bo Young Jang; So Young Bu
Journal:  Nutr Res Pract       Date:  2018-05-23       Impact factor: 1.926

4.  Development of Taiwan Risk Score for Sarcopenia (TRSS) for Sarcopenia Screening among Community-Dwelling Older Adults.

Authors:  Tzyy-Guey Tseng; Chun-Kuan Lu; Yu-Han Hsiao; Shu-Chuan Pan; Chi-Jung Tai; Meng-Chih Lee
Journal:  Int J Environ Res Public Health       Date:  2020-04-21       Impact factor: 3.390

5.  Association of Dietary Variety Status and Sarcopenia in Korean Elderly.

Authors:  Hee-Sook Lim
Journal:  J Bone Metab       Date:  2020-05-31

6.  Association Between Sarcopenic Obesity and Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis.

Authors:  Dima Khadra; Leila Itani; Yomna Chebaro; May Obeid; Miryam Jaber; Reham Ghanem; Agnes Ayton; Dima Kreidieh; Dana E Masri; Akira Kimura; Hana Tannir; Marwan El Ghoch
Journal:  Curr Cardiol Rev       Date:  2020

7.  Effects of Adherence to a Higher Protein Diet on Weight Loss, Markers of Health, and Functional Capacity in Older Women Participating in a Resistance-Based Exercise Program.

Authors:  Melyn Galbreath; Bill Campbell; Paul LaBounty; Jennifer Bunn; Jacqueline Dove; Travis Harvey; Geoffrey Hudson; Jean L Gutierrez; Kyle Levers; Elfego Galvan; Andrew Jagim; Lori Greenwood; Matthew B Cooke; Mike Greenwood; Chris Rasmussen; Richard B Kreider
Journal:  Nutrients       Date:  2018-08-11       Impact factor: 5.717

8.  The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass.

Authors:  Eun Kyung Choe; Hae Yeon Kang; Boram Park; Jong In Yang; Joo Sung Kim
Journal:  J Clin Med       Date:  2018-09-28       Impact factor: 4.241

9.  Association between Sarcopenic Obesity, Type 2 Diabetes, and Hypertension in Overweight and Obese Treatment-Seeking Adult Women.

Authors:  Dima Kreidieh; Leila Itani; Dana El Masri; Hana Tannir; Roberto Citarella; Marwan El Ghoch
Journal:  J Cardiovasc Dev Dis       Date:  2018-10-20

10.  Poor Physical Function as a Marker of Sarcopenia in Adults with Class II/III Obesity.

Authors:  Carlene A Johnson Stoklossa; Sunita S Ghosh; Mary Forhan; Arya M Sharma; Tasuku Terada; Mario Siervo; Vickie E Baracos; Raj S Padwal; Pam A Hung; Michael B Sawyer; Yara Lm Maia; Carla M Prado
Journal:  Curr Dev Nutr       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.